North Carolina Hospital To Participate In CDC Infection Control Study

January 3, 2013

One of the major medical errors that has led to countless North Carolina Medical Malpractice lawsuits being filed is post operative or procedural infection. To help reduce the problem at one Burlington, North Carolina, hospital, the facility has agreed to participate in a government-funded study that will examine certain new methods of infection control.

According to an article published by Infection Control Today, the Alamance Regional Medical Center has agreed to take part in research being conducted by the Centers for Disease Control and Prevention (CDC) that will examine the effectiveness of Ultra-Violet (UV) disinfection technology over the next two-years. The study will specifically examine the effectiveness of the Tru-D SmartUVC™, which radiates a UV-C energy that has been found effective in breaking down the DNA of bacteria, spores, and viruses. Breaking of the DNA kills off the organism by preventing their ability to reproduce. The technology will be used to cleanse the rooms of patients who suffer from infections like MRSA, VRE, C. difficile and Acinetobacter.

Tru-D SmartUVC™ technology has been shown to be more effective in reducing levels of contaminates than more traditional methods of cleaning because of a patented technology that can measure and administer lethal doses of the energy in precarious locations in a room, like under a bed or in a dark corner.

The North Carolina Personal Injury Lawyers with HensonFuerst Injury Lawyers are hopeful the new technology will be successful in better protecting the safety of patients undergoing medical procedures.